Health impact and cost-effectiveness of a domestically-produced rotavirus vaccine in India: A model based analysis
Table 4
Expected clinical events and utilization in a birth cohort of 100,000 Indian infants followed for 5 years under strategies of no vaccination and vaccination using 116E.